Inogen, Inc. (INGN)
USD 7.05
(-2.08%)
USD 7.05
(-2.08%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 236.08 Million USD | 7.67% |
| 2022 | 186.61 Million USD | 11.58% |
| 2021 | 167.24 Million USD | 11.34% |
| 2020 | 150.2 Million USD | -1.23% |
| 2019 | 152.07 Million USD | 8.09% |
| 2018 | 140.68 Million USD | 50.23% |
| 2017 | 93.64 Million USD | 25.79% |
| 2016 | 74.44 Million USD | 21.63% |
| 2015 | 61.2 Million USD | 36.0% |
| 2014 | 45 Million USD | 30.35% |
| 2013 | 34.52 Million USD | 49.34% |
| 2012 | 23.12 Million USD | 40.75% |
| 2011 | 16.42 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 48.9 Million USD | -3.04% |
| 2024 Q2 | 53.18 Million USD | 8.75% |
| 2023 FY | 200.92 Million USD | 7.67% |
| 2023 Q4 | 50.43 Million USD | 5.98% |
| 2023 Q3 | 47.59 Million USD | 3.88% |
| 2023 Q2 | 45.81 Million USD | -12.98% |
| 2023 Q1 | 52.64 Million USD | 47.07% |
| 2022 Q1 | 48.59 Million USD | 7.36% |
| 2022 Q3 | 53.09 Million USD | 8.05% |
| 2022 Q2 | 49.13 Million USD | 1.12% |
| 2022 FY | 186.61 Million USD | 11.58% |
| 2022 Q4 | 35.79 Million USD | -32.57% |
| 2021 Q1 | 42 Million USD | 6.12% |
| 2021 Q2 | 38.66 Million USD | -7.95% |
| 2021 FY | 167.24 Million USD | 11.34% |
| 2021 Q3 | 41.31 Million USD | 6.85% |
| 2021 Q4 | 45.26 Million USD | 9.56% |
| 2020 Q4 | 39.58 Million USD | 13.16% |
| 2020 FY | 150.2 Million USD | -1.23% |
| 2020 Q3 | 34.97 Million USD | -0.34% |
| 2020 Q2 | 35.1 Million USD | -13.43% |
| 2020 Q1 | 40.54 Million USD | 3.32% |
| 2019 Q1 | 39.55 Million USD | 1.95% |
| 2019 FY | 152.07 Million USD | 8.09% |
| 2019 Q4 | 39.24 Million USD | 11.46% |
| 2019 Q3 | 35.2 Million USD | -7.52% |
| 2019 Q2 | 38.07 Million USD | -3.74% |
| 2018 Q4 | 38.79 Million USD | 0.98% |
| 2018 FY | 140.68 Million USD | 50.23% |
| 2018 Q3 | 38.41 Million USD | 11.52% |
| 2018 Q2 | 34.44 Million USD | 18.68% |
| 2018 Q1 | 29.02 Million USD | 13.54% |
| 2017 FY | 93.64 Million USD | 25.79% |
| 2017 Q1 | 20.17 Million USD | 8.94% |
| 2017 Q2 | 23.07 Million USD | 14.36% |
| 2017 Q3 | 24.83 Million USD | 7.66% |
| 2017 Q4 | 25.56 Million USD | 2.93% |
| 2016 FY | 74.44 Million USD | 21.63% |
| 2016 Q1 | 18 Million USD | 8.68% |
| 2016 Q3 | 19.73 Million USD | 8.44% |
| 2016 Q4 | 18.51 Million USD | -6.15% |
| 2016 Q2 | 18.19 Million USD | 1.08% |
| 2015 Q2 | 15.47 Million USD | 14.6% |
| 2015 Q4 | 16.56 Million USD | 5.77% |
| 2015 Q3 | 15.66 Million USD | 1.19% |
| 2015 Q1 | 13.5 Million USD | 9.05% |
| 2015 FY | 61.2 Million USD | 36.0% |
| 2014 Q4 | 12.38 Million USD | 11.75% |
| 2014 Q2 | 11.15 Million USD | 7.33% |
| 2014 Q1 | 10.38 Million USD | 7.97% |
| 2014 Q3 | 11.08 Million USD | -0.62% |
| 2014 FY | 45 Million USD | 30.35% |
| 2013 Q1 | 7.48 Million USD | 9.56% |
| 2013 Q2 | 8.66 Million USD | 15.78% |
| 2013 FY | 34.52 Million USD | 49.34% |
| 2013 Q4 | 9.62 Million USD | 9.89% |
| 2013 Q3 | 8.75 Million USD | 1.05% |
| 2012 Q4 | 6.83 Million USD | 11.15% |
| 2012 Q3 | 6.14 Million USD | 0.0% |
| 2012 FY | 23.12 Million USD | 40.75% |
| 2011 FY | 16.42 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -2003.395% |
| Cerus Corporation | 143.15 Million USD | -64.916% |
| OrthoPediatrics Corp. | 137.01 Million USD | -72.301% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1978.055% |
| Talis Biomedical Corporation | 67.18 Million USD | -251.39% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -846.384% |
| Spectral AI, Inc. | 20.86 Million USD | -1031.542% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -321.603% |
| CVRx, Inc. | 76.14 Million USD | -210.059% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -6591.759% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1790.344% |
| Orthofix Medical Inc. | 667.42 Million USD | 64.628% |
| Venus Concept Inc. | 80.47 Million USD | -193.361% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -317.273% |
| Bioventus Inc. | 409.91 Million USD | 42.407% |
| BrainsWay Ltd. | 28.01 Million USD | -742.619% |
| Envoy Medical, Inc. | 17.89 Million USD | -1219.058% |
| electroCore, Inc. | 32.03 Million USD | -637.052% |
| IceCure Medical Ltd | 16.87 Million USD | -1298.939% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -456.384% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -1238.88% |
| MaxCyte, Inc. | 84.84 Million USD | -178.254% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1802.106% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3983.558% |
| PAVmed Inc | 64.82 Million USD | -264.177% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -362.205% |
| RxSight, Inc. | 103.85 Million USD | -127.333% |
| Sight Sciences, Inc. | 126.44 Million USD | -86.704% |
| SI-BONE, Inc. | 156.35 Million USD | -50.997% |
| TELA Bio, Inc. | 84.18 Million USD | -180.429% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -236.995% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -16.089% |
| LivaNova PLC | 843.54 Million USD | 72.013% |
| 908 Devices Inc. | 68.08 Million USD | -246.776% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 51.182% |
| Nemaura Medical Inc. | 7.13 Million USD | -3207.067% |
| NeuroPace, Inc. | 75.29 Million USD | -213.543% |
| LENSAR, Inc. | 33.33 Million USD | -608.198% |
| Apyx Medical Corporation | 51.01 Million USD | -362.748% |
| Cutera, Inc. | 197.72 Million USD | -19.401% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -852.686% |
| BioSig Technologies, Inc. | 28.53 Million USD | -727.497% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -23.298% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -554.7% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 71.773% |
| Axonics, Inc. | 270.2 Million USD | 12.626% |
| Outset Medical, Inc. | 198.77 Million USD | -18.773% |
| IRIDEX Corporation | 31.81 Million USD | -642.079% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -30.999% |
| IRadimed Corporation | 30.12 Million USD | -683.742% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -2667.053% |
| INVO Bioscience, Inc. | 7.85 Million USD | -2906.191% |
| Telesis Bio, Inc. | 63.48 Million USD | -271.852% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -139.795% |
| Varex Imaging Corporation | 224.8 Million USD | -5.02% |
| Quipt Home Medical Corp. | 148.66 Million USD | -58.801% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1913.862% |
| Pulmonx Corporation | 112.68 Million USD | -109.505% |
| Dynatronics Corporation | 9.9 Million USD | -2282.765% |
| Modular Medical, Inc. | 17.52 Million USD | -1246.825% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -1069.49% |
| Semler Scientific, Inc. | 38.94 Million USD | -506.217% |
| InMode Ltd. | 215.68 Million USD | -9.461% |
| Bruker Corporation | 1.07 Billion USD | 78.067% |
| Cytosorbents Corporation | 48.33 Million USD | -388.416% |
| DexCom, Inc. | 1.69 Billion USD | 86.04% |
| Align Technology, Inc. | 2.07 Billion USD | 88.632% |
| Viveve Medical, Inc. | 22.17 Million USD | -964.741% |
| ZimVie Inc. | 275.12 Million USD | 14.19% |
| Movano Inc. | 29.69 Million USD | -695.167% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -71.985% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3983.558% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -6591.759% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 60.713% |
| Profound Medical Corp. | 33.6 Million USD | -602.568% |
| Insulet Corporation | 939.9 Million USD | 74.882% |
| enVVeno Medical Corporation | 25.23 Million USD | -835.435% |
| Surmodics, Inc. | 98.69 Million USD | -139.202% |
| iCAD, Inc. | 22.22 Million USD | -962.25% |
| Nuwellis, Inc. | 22.61 Million USD | -944.023% |
| Biotricity, Inc. | 17.18 Million USD | -1273.821% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 47.053% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1822.906% |
| InspireMD, Inc. | 22.95 Million USD | -928.693% |
| PAVmed Inc. | 64.82 Million USD | -264.177% |
| BIOLASE, Inc. | 34.66 Million USD | -581.126% |
| Beyond Air, Inc. | 61.7 Million USD | -282.634% |
| FONAR Corporation | 28.6 Million USD | -725.337% |
| AxoGen, Inc. | 149.33 Million USD | -58.09% |
| Vivani Medical, Inc. | 26.96 Million USD | -775.524% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -33.312% |
| Inari Medical, Inc. | 448.59 Million USD | 47.372% |
| UFP Technologies, Inc. | 58.08 Million USD | -306.419% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -4691.076% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -3636.534% |
| Tenon Medical, Inc. | 16.96 Million USD | -1291.354% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -3093.359% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -435.306% |
| AdaptHealth Corp. | 1.07 Billion USD | 78.099% |
| Sintx Technologies, Inc. | 15.2 Million USD | -1453.089% |
| NanoVibronix, Inc. | 4.97 Million USD | -4647.336% |
| Quanterix Corporation | 118.1 Million USD | -99.903% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1913.862% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -1534.711% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 39.876% |
| TransMedics Group, Inc. | 182.82 Million USD | -29.135% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -741.208% |
| NeuroMetrix, Inc. | 11.09 Million USD | -2027.096% |
| Hyperfine, Inc. | 52.87 Million USD | -346.522% |
| Establishment Labs Holdings Inc. | 172 Million USD | -37.256% |
| Biomerica, Inc. | 6.97 Million USD | -3283.276% |
| Bone Biologics Corporation | 9.42 Million USD | -2404.003% |
| AVITA Medical, Inc. | 80.77 Million USD | -192.26% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -2189.594% |
| Silk Road Medical, Inc | 186.35 Million USD | -26.684% |